Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Cited by Google 
Similars in
SciELO 
Similars in Google
Share
Permalink
Revista Ciencias de la Salud
Print version ISSN 1692-7273On-line version ISSN 2145-4507
Abstract
SOTO-PENA, Diana Pilar et al. Position Statement: Recommendations on Use of Follow-Up Scales and Assessment and Management of Bone Health in Duchenne Muscular Dystrophy. Rev. Cienc. Salud [online]. 2025, vol.23, n.spe, e23e3. Epub Apr 22, 2025. ISSN 1692-7273. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.14006.
Duchenne muscular dystrophy (DMD) is a disease characterized by progressive muscle weakness. Glucocorticoids have been shown to prolong the time of ambulation, decrease the rate of progression of DMD complications, and also extend survival. However, their prolonged use is associated to side effects such as alterations in bone microarchitecture and weight gain. The initiation of treatment and the monitoring of disease progression depends on the patient's functional status, which is assessed using motor function scales that predict functional outcomes and evaluate the impact of interventions. This article provides recommendations on the use of monitoring scales and the evaluation and management of bone health in patients with DMD.
Materials and methods:
An expert panel of 26 physicians from different specialties with knowledge and experience in managing patients with Duchenne muscular dystrophy was formed. Two specialists drafted recommendations on the use of monitoring scales and two others on the evaluation and management of bone health in DMD, based on literature review and their knowledge and experience on the topic.
Conclusions:
It is recommended to monitor patients with Duchenne muscular dystrophy every six months, using functional scales that may vary according to the patient's clinical status. Additionally, assessment of bone health, measurement of 25-oh vitamin D levels, and nutritional recommendations for calcium intake are essential. In patients progressing to osteoporosis, intravenous bisphosphonate management should be performed.
Keywords : Duchenne muscular dystrophy; expert position; recommendations; bone density; osteoporosis; functional scales; functional status.
